Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1

NCT00109772 is registered in ClinicalTrials.gov with Celgene Corporation as lead sponsor.

NCT NCT00109772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00109772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1
Lead sponsor
Celgene Corporation
Phase
Phase 2
Overall status
Terminated
Start date
February 28, 2005
Completion date
April 30, 2008
Enrollment
184 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

complex regional pain syndrome, type i